Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis

BACKGROUND: The development of an effective vaccine against visceral leishmaniasis (VL) caused by Leishmania donovani is an essential aim for controlling the disease. Use of the right adjuvant is of fundamental importance in vaccine formulations for generation of effective cell-mediated immune respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravindran, Rajesh, Bhowmick, Sudipta, Das, Amrita, Ali, Nahid
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904331/
https://www.ncbi.nlm.nih.gov/pubmed/20576102
http://dx.doi.org/10.1186/1471-2180-10-181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904331/
https://www.ncbi.nlm.nih.gov/pubmed/20576102
http://dx.doi.org/10.1186/1471-2180-10-181

Ejemplares similares